Medsafe: New Zealand Medicines and Medical Devices Safety Authority

MEDSAFE


New Zealand Medicines and Medical
Devices Safety Authority

Revised: 26 August 2026

Medicines

 

Medsafe Product Detail

Related Product

File ref: TT50-8992
Trade Name Dose Form Strength Identifier
Blackmores Iodine 150 mcg Film coated tablet 150 mcg
Sponsor Application date Regulatory status Classification
Blackmores (NZ) Ltd
P O Box 11523
Ellerslie
Auckland 1542
13/02/2012 Approval lapsed
Approval date:9/08/2012
Notification date: 27/08/2020
General sale

Composition

Component Ingredient Manufacturer
film coated tabletActive 
 Potassium iodide 196ug equivalent to to Iodine 150 mcgB.G.R. Chemical Products Inc
600 Avenue Delmar
Pointe-Claire QC H9R 4A8
CANADA
 Excipient 
 Calcium hydrogen phosphate
 Carnauba wax
 Hypromellose
 Iron oxide yellow
 Microcrystalline cellulose
 Opadry white YS-1-7027
 Triacetin

Production

Manufacturing step Manufacturer
Finished Product TestingLipa Pharmaceuticals Ltd
21 Reaghs Farm Rd
Minto
NSW 2566
AUSTRALIA
Manufacture of Active IngredientB.G.R. Chemical Products Inc
600 Avenue Delmar
Pointe-Claire QC H9R 4A8
CANADA
Manufacture of Final Dose FormLipa Pharmaceuticals Ltd
21 Reaghs Farm Rd
Minto
NSW 2566
AUSTRALIA
PackingBlackmores (Australia) Ltd
20 Jubilee Avenue
Warriewood
NSW 2102
AUSTRALIA
NZ Site of Product ReleaseBlackmores (NZ) Ltd
14-16 Norman Spencer Drive
Wiri
Manukau City 2104

Packaging

Package Contents Shelf life
Bottle, glass, Amber with white J cap90 tablets24 months from date of manufacture stored at or below 30°C protect from light

Indications

Iodine supplement during pregnancy and breastfeeding, to help support baby's normal brain and nervous system development.

Latest Regulatory Activity

Application DateApplication TypeChange(s)StatusPayment DatePriority
13/02/2012New Related Product ApplicationNew related productGranted21/02/2012